Skip to content

A CLINICAL STUDY TO COMPARE THE EFFICACY OF VRISHADI NIRUHA BASTI WITH AND WITHOUT SIRAVYADHA IN THE MANAGEMENT OF GRIDHRASI VIS-A-VIS SCIATICA

AN OPEN LABELLED RANDOMISED CLINICAL STUDY TO COMPARE THE EFFICACY OF VRISHADI NIRUHA BASTI WITH AND WITHOUT THE SIRAVYADHA IN THE MANAGEMENT OF GRIDHRASI VIS-A- VIS SCIATICA - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103586
Enrollment
30
Registered
2026-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Dr Ujwal Razdan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects presenting with classical signs and symptoms of Gridhrasi vis-a-vis Sciatica. 2.Subjects with a positive Straight Leg Raise (SLR) test upto 70 and Bragard s sign on the affected limb. 3. Subjects fit for both Basti Karma and Siravyadha procedures, based on proper clinical examination. 4. Subjects who willingly agree to participate in the study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Subjects unfit for Siravyadha or Basti Karma, due to medical contraindications. 2.Subjects with systemic illnesses that may interfere with the course of treatment, such as uncontrolled hypertension, uncontrolled diabetes, Koch s spine or hip, malignancy etc. 3.Subjects with structural spinal conditions like compression fractures, lumbar canal stenosis, Quada equina compression, ankylosing spondylitis, post-surgical spine status, spinal deformities, or avascular necrosis of the femoral head. 4.Subjects who are pregnant or lactating.

Design outcomes

Primary

MeasureTime frame
1.Assessment of Ruk, Stambha, Spandana, Toda and objective parameters like Straight Leg Raise (SLR) test and Schober s test. 2.Establishment of clinical efficacy of Vrishadi Niruha Basti with and without Siravyadha in the management of Gridhrasi vis-a-vis Sciatica.Timepoint: Group A: Siravyadha followed by Vrishadi Niruha Basti Trial period 12 days Initial assessment 0th day Assessment on - 1st day(post Siravyadha) 12th day (post Basti) Follow up - 32nd day Total study duration - 32 days. Group B: Vrishadi Niruha Basti alone Trial period 11 days Initial assessment 0th day Assessment on - 11th day Follow up - 31st day Total study duration - 31 days.

Secondary

MeasureTime frame
1. Improvement in Functional Disability- Measured by Oswestry Disability Index (ODI)Timepoint: Group A: Siravyadha followed by Vrishadi Niruha Basti Trial period 12 days Initial assessment 0th day Assessment on - 1st day(post Siravyadha) 12th day (post basti) Follow up - 32nd day Total study duration - 32 days. Group B: Vrishadi Niruha Basti alone Trial period 11 days Initial assessment 0th day Assessment on - 11th day Follow up - 31st day Total study duration - 31 days.

Countries

India

Contacts

Public ContactDr Madhushree H S

Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore

drmadhushreehs@rediffmail.com9916058006

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026